Academic literature on the topic 'Pharmaceutical Potential'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmaceutical Potential.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmaceutical Potential"

1

Akash, Muhammad Sajid Hamid, Kanwal Rehman, Shakila Sabir, Javeria Gul, and Iqbal Hussain. "Review Potential Risk Assessment of Pharmaceutical Waste: Critical Review and Analysis." Pakistan Journal of Scientific & Industrial Research Series A: Physical Sciences 63, no. 3 (2020): 209–19. http://dx.doi.org/10.52763/pjsir.phys.sci.63.3.2020.209.219.

Full text
Abstract:

 Nowadays, pharmaceutical waste has been considered as an environmental micro pollutant due to its unavoidable occurrence in the ecosystem and has become a major health issue. Pharmaceutical products are formulated to therapeutically influence the physiological systems, however, their potential health concerns which contribute in increasing environmental pollution like other most potential environmental pollutants still needs to be taken under consideration by the healthcare professionals and environmental experts. So, the contamination of treated wastewater by pharmaceutical waste and o
APA, Harvard, Vancouver, ISO, and other styles
2

Kemp, Terence J. "Ionic Liquids – Pharmaceutical Potential." Science Progress 95, no. 2 (2012): 224–30. http://dx.doi.org/10.3184/003685012x13359550637125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kaur, Indu Pal, Kanwaljit Chopra, and Amarpreet Saini. "Probiotics: potential pharmaceutical applications." European Journal of Pharmaceutical Sciences 15, no. 1 (2002): 1–9. http://dx.doi.org/10.1016/s0928-0987(01)00209-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

P, Subashini. "Strategic insights: Unveiling the potential of Pharmaceutical exports from India to Regulated markets." Journal of Medical Pharmaceutical and Allied Sciences 13, no. 5 (2024): 9483–790. http://dx.doi.org/10.55522/jmpas.v13i5.6617.

Full text
Abstract:
India is a major exporter of medicinal products in the world. India's pharmaceutical sector has grown significantly to contribute largely to the GDP of the nation because of its rapidly expanding economy and abundance of highly skilled labor. However, exporting pharmaceuticals to markets that are subject to regulations can be a difficult procedure that requires a lot of paperwork. This all-inclusive handbook will assist in navigating the documentation and export regulatory requirements for pharmaceutical exports from India to regulated markets. It also provides export projections for the futur
APA, Harvard, Vancouver, ISO, and other styles
5

Nasir, Fazli. "Welcome to Pharmaceutical Communications." Pharmaceutical Communications 1, no. 01 (2022): 01. http://dx.doi.org/10.55627/pharma.001.001.0203.

Full text
Abstract:
Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stabil
APA, Harvard, Vancouver, ISO, and other styles
6

Premjit, G. Pawar. "EXPLORING THE POTENTIAL OF NANOTECHNOLOGY IN ENHANCING THE EFFICACY AND OF PHARMACEUTICAL COSMETICS." International Journal in Pharmaceutical Sciences 2, no. 1 (2024): 690–97. https://doi.org/10.5281/zenodo.10574353.

Full text
Abstract:
Nanotechnology has emerged as a promising field with significant potential in various industries, including pharmaceuticals and cosmetics. In the realm of pharmaceutical cosmetics, the application of nanotechnology offers opportunities to enhance both efficacy and safety. This paper explores the potential of nanotechnology in improving the performance of pharmaceutical cosmetics, focusing on its ability to enhance skin penetration, target specific skin layers, and improve the bioavailability of active ingredients. Additionally, the safety consideration associated with nanomaterials in cosmetic
APA, Harvard, Vancouver, ISO, and other styles
7

Lu, Zhiqiang, Zaina Parvez Qureshi, Brian Chen, et al. "Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse." Blood 120, no. 21 (2012): 4275. http://dx.doi.org/10.1182/blood.v120.21.4275.4275.

Full text
Abstract:
Abstract Abstract 4275 Introduction: Annually, $82 billion to $272 billion is reportedly lost to federal health care fraud. Between 1996 and 2005, 379 federal health care fraud cases initiated by qui tam relators (“whistle blowers”) concluded, resulting in $9.3 billion in recoveries. Of these, pharmaceutical companies accounted for 13 cases (False Claims Act (FCA) cases, the primary statute invoked in health care fraud and abuse), but $3.9 billion of recoveries (4% of the cases and 39% of the financial recoveries). We report concluded FCA cases involving pharmaceutical manufacturers between 20
APA, Harvard, Vancouver, ISO, and other styles
8

Jha, Swati, Prateek Mathur, Suman Ramteke, and Narendra Kumar Jain. "Pharmaceutical potential of quantum dots." Artificial Cells, Nanomedicine, and Biotechnology 46, sup1 (2017): 57–65. http://dx.doi.org/10.1080/21691401.2017.1411932.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

V, Soni. "The Potential of Biosurfactants in the Pharmaceutical Industry: A Review." Bioequivalence & Bioavailability International Journal 6, no. 2 (2022): 1–15. http://dx.doi.org/10.23880/beba-16000176.

Full text
Abstract:
Surface-active substances known as "bio-based surfactants" come from a variety of sources, including plants, animals, microorganisms, marine life, synthetics, and semi-synthetics. Bio-based surfactants have a variety of uses, including in food, personal care, pharmaceutical, and industrial formulations as well as in agricultural and oil field chemicals and institutional and industrial cleaning. Nowadays, there is a significant demand for bio-based surfactants on the market as a result of the strict environmental rules that governments across the globe have placed on the use of toxins in deterg
APA, Harvard, Vancouver, ISO, and other styles
10

P, Aastha Dhingra1 Sirajuddin Ahmed*2 Weqar Ahmed Siddiqui1 Siddhartha Gautam3 &. Nadeem A. Khan2. "IDENTIFICATION OF PRIORITY PHARMACEUTICAL RESIDUES IN HOSPITAL EFFLUENTS." GLOBAL JOURNAL OF ENGINEERING SCIENCE AND RESEARCHES 5, no. 7 (2018): 420–35. https://doi.org/10.5281/zenodo.1320966.

Full text
Abstract:
The pharmaceutical residues are commonly found in aquatic environment throughout the world. The pharmaceutical residue increases the microbial resistance, reduces the self purification capacities of the water bodies, adversely impacts the aquatic life being ecotoxic and few are also known to be teratogenic, mutagenic and even genotoxic. Despite of well documented and known potential implications of pharmaceutical residues, they persist in the aquatic environment and there are still no specific discharge standards. This study has attempted to consider extensive set of important parameters for i
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharmaceutical Potential"

1

Cheung, Wai-Han. "Novel steroidal metal complexes with potential pharmaceutical applications." Thesis, Loughborough University, 1992. https://dspace.lboro.ac.uk/2134/27879.

Full text
Abstract:
A study to develop novel lipophilic metal ion complexes based on dihydrocholesterol was undertaken. Steroid ligands functionalised at the 2- and 3- positions were synthesized as possible bidentate ligands for complexation of metal ions. Condensation of 5α-cholestan-3-one with ethyl formate in the presence of base gave 2-hydroxymethylene-5α-cholestan-3-one, and 2- acetyl-5α-cholestan-3-one was obtained by the reaction between 3- trimethylsilyloxy-5α-cholest-2-ene and acetyl chloride. Attempts to synthesize 2,3-dioximino-5α-cholestane from 5α-cholestan-3-one and 2α-hydroxy-5α-cholestan-3-one wer
APA, Harvard, Vancouver, ISO, and other styles
2

Umemura, Maki. "Unrealised potential : Japan's post-war pharmaceutical industry, 1945-2005." Thesis, London School of Economics and Political Science (University of London), 2008. http://etheses.lse.ac.uk/2172/.

Full text
Abstract:
Japan's existing pharmaceutical industry was devastated in the Second World War. But the industry recovered quickly, and in 1963, Japan had become the second largest producer of pharmaceuticals after the United States. Unlike its automobile or electronics industries, however, Japan's pharmaceutical industry did not become a global leader. Japan remains a net importer of pharmaceuticals and few Japanese drugs are found outside of Japan. The global pharmaceutical industry is led by firms from the United States, the United Kingdom and Switzerland, rather than those from Japan. This thesis traces
APA, Harvard, Vancouver, ISO, and other styles
3

Woolley, Ley Hwee. "Synthesis of potential anthelminthic drugs." Thesis, University of Salford, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.258257.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hardman, Mark Alan. "Design of potential antiprotozoal daunorubicin derivatives." Thesis, De Montfort University, 1985. http://hdl.handle.net/2086/10737.

Full text
Abstract:
Daunorubicin is an antitumour antibiotic which is highly active against the sleeping sickness parasite Trypanosoma rhodesiense in vitro, but which lacks in vivo activity. The object of this work was to modify daunorubicin so as to promote in vivo activity, and to study the mechanism by which daunorubicin is trypanocidal. A series of daunorubicin analogues, and derivatives in which daunorubicin was linked to a macromolecular carrier (known as daunorubicin conjugates) were prepared, and tested against trypanosome infected mice. Only daunorubicin conjugates in which drug was linked to the carrier
APA, Harvard, Vancouver, ISO, and other styles
5

Setiawan, Nico. "UNDERSTANDING THE THERMODYNAMICS AND ORAL ABSORPTION POTENTIAL OF PHARMACEUTICAL AMORPHOUS SOLID DISPERSIONS." UKnowledge, 2018. https://uknowledge.uky.edu/pharmacy_etds/85.

Full text
Abstract:
Supersaturating drug delivery systems, such as amorphous solid dispersions (ASDs), have been used extensively to elevate the apparent solubility and oral bioavailability of poorly water-soluble drugs. However, despite the numerous examples of success in increasing solubility and oral bioavailability using ASDs, physical stability challenges remain as formulators seek to employ high drug loading for cost reduction and improved patient compliance. Therefore, stability in both the solid and solution state must be considered for ASDs to be successful. In the solid state, the drug must remain amorp
APA, Harvard, Vancouver, ISO, and other styles
6

Patel, Sanjay S. "Potential short-acting chemodegradable neuromuscular blocking agents." Thesis, University of Bath, 1989. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.234653.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dentali, Steven John. "Potential antiinfective agents from Eriodictyon angustifolium Nutt. and Salvia apiana Jeps." Diss., The University of Arizona, 1991. http://hdl.handle.net/10150/185511.

Full text
Abstract:
The dichloromethane extracts of twelve US Southwestern herbal remedies were tested against Staphylococcus aureus (9-29 UA), Bacillus subtilis (2-27 UA), Klebsiella pneumoniae (3-9 UA), and Candida brassicae (IFO 1664) in an agar dilution-streak bioassay at 1000 μg/ml. All twelve plants inhibited the growth of B. subtilis. Anemopsis californica, Berberis fendleri, Cacalia decomposita, and Eriodictyon angustifolium inhibited the growth of at least two organisms. Salvia apiana was the only plant in this study to completely inhibit the growth of all four test organisms. After a literature search l
APA, Harvard, Vancouver, ISO, and other styles
8

Manson, Andrew John. "The production and potential of antibodies to morphine." Thesis, University of Sunderland, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.303249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gordge, Philip Charles. "Potential agonists and inhibitors of protein kinase C." Thesis, University College London (University of London), 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kennedy, Joakim. "Pharmaceutical engineering of microneedle-mediated intradermal nanoparticle delivery device : potential for lymphatic targeting." Thesis, Queen's University Belfast, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.706993.

Full text
Abstract:
Microneedles (MNs) are minimally invasive drug delivery devices that can be used for transdermal drug delivery (TDD). They have the potential to enhance drug delivery for therapeutic agents which are currently difficult to deliver, costly, or cause a wide range of side effects. The therapeutic agent must normally overcome the highly hydrophobic barrier of the skin’s outermost layer, the stratum corneum (s.c.), in order to be delivered transdermally. MNs have a height of 50 m to 1500 m and overcome the barrier by penetrating the s.c. and creating aqueous pores. They can be fabricated from diffe
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pharmaceutical Potential"

1

Mehmood, Muhammad Aamer, Pradeep Verma, Maulin P. Shah, and Michael J. Betenbaugh, eds. Pharmaceutical and Nutraceutical Potential of Cyanobacteria. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-45523-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Natale, Valerie. Proteomics: An assessment of technology and commercial potential. Business Communications Co., 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Paolo, Milani, Da Ros Tatiana, and SpringerLink (Online service), eds. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes. Springer Science + Business Media B.V, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nandi, Rajib. Herbal medicinal plants in Himachal Pradesh: An analysis of income and employment potential. Institute of Social Studies Trust, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Barnes, Andrew Richard. Detection and assay of hydroxyl radicals by chemical means of potential application to pharmaceutical stability studies. Leicester Polytechnic, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Asdrubolini, Tania. Chromatographic identification of organic compounds occurring in Dandelion and Devil's Claw Roots which may have potential pharmaceutical activity. Laurentian University, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pisano, Gary P. The development factory: Unlocking the potential of process innovation. Harvard Business School Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

E, Lumley C., McAuslane J. A. Neil, and Centre for Medicines Research International (Carshalton, London, England), eds. Assessment of pharmaceuticals for potential human carcinogenic risk. CMR International, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

California. Legislature. Senate. Committee on Health and Human Services. Informational hearing of the Senate Health and Human Services Committee: The impact of federal policy on realizing the potential of stem cell research. Senate Publications, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sidorenko, Oleg, Ekaterina Zhukova, Aleksey Ivanov, and Lyudmila Kostyuchenko. Sitology and lactotherapy. INFRA-M Academic Publishing LLC., 2022. http://dx.doi.org/10.12737/1852468.

Full text
Abstract:
The textbook demonstrates the biochemical features of lactobacilli of different geographical races isolated from national dairy products of different countries and climatogeographic zones. The issues of the potential use of lactobacilli in the composition of dairy therapeutic and prophylactic products for gastrointestinal diseases and the creation of probiotics are considered. The literature data and the results of the authors' own research are analyzed.
 Meets the requirements of the federal state educational standards of higher education of the latest generation. 
 It is intended f
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pharmaceutical Potential"

1

Nahler, Gerhard. "therapeutic potential." In Dictionary of Pharmaceutical Medicine. Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_1391.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Working, Peter K. "Potential Effects of Antibody Induction by Protein Drugs." In Pharmaceutical Biotechnology. Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-2329-5_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Paz-Montelongo, Soraya, Cintia Hernández-Sánchez, Fernando Guillén-Pino, Carmen Rubio-Armendáriz, Ángel J. Gutiérrez-Fernández, and Arturo Hardisson. "Cyanobacterial Pigments: Pharmaceutical and Nutraceutical Applications." In Pharmaceutical and Nutraceutical Potential of Cyanobacteria. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-45523-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Xia, Rong, Kim Dekermendjian, Elke Lullau, and Niek Dekker. "TRPV1: A Therapy Target That Attracts the Pharmaceutical Interests." In Transient Receptor Potential Channels. Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-94-007-0265-3_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mazza, M., M. Alonso-Sande, M. C. Jones, and M. de la Fuente. "The Potential of Nanoemulsions in Biomedicine." In Fundamentals of Pharmaceutical Nanoscience. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9164-4_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nair, Preetha, Telphy Kuriakose, and Bannhi Das. "Pharmaceutical Applications of Microbial Proteases." In Microbial Enzymes as Potential Biotherapeutics in Human Healthcare. CRC Press, 2025. https://doi.org/10.1201/9781003473008-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

De Muth, James E. "Tests to Evaluate Potential Outliers." In Practical Statistics for Pharmaceutical Analysis. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-33989-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Darmawan, Muhamad, Nurrahmi Dewi Fajarningsih, Sihono, and Hari Eko Irianto. "Caulerpa: Ecology, Nutraceutical and Pharmaceutical Potential." In Marine Niche: Applications in Pharmaceutical Sciences. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-5017-1_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jeewon, Rajesh, Amiirah Bibi Luckhun, Vishwakalyan Bhoyroo, et al. "Pharmaceutical Potential of Marine Fungal Endophytes." In Bioactive Molecules in Food. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-76900-4_6-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

O'Keeffe, Catherina M., Gary W. Stutte, and Michelle McKeon-Bennett. "Ragwort: Invasive Weed and Potential Pharmaceutical." In Horticultural Reviews: Volume 43. John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781119107781.ch03.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmaceutical Potential"

1

Gao, Junyao, Jinfei Meng, Yuming Zhao, Xiandong Xu, and Yuze Zhao. "Adjustable Potential Analysis of Cleanrooms For Pharmaceutical Industries." In 2024 IEEE PES 16th Asia-Pacific Power and Energy Engineering Conference (APPEEC). IEEE, 2024. https://doi.org/10.1109/appeec61255.2024.10922440.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Barhate, Yash, Yung Shun Kang, Neda Nazemifard, et al. "Data-driven Digital Design of Pharmaceutical Crystallization Processes." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.128994.

Full text
Abstract:
Mechanistic population balance modeling (PBM) has advanced the design of pharmaceutical crystallization processes, enabling the production of active pharmaceutical ingredient (API) crystals with desired critical quality attributes (CQAs), such as purity and crystal size distribution. However, PBM development can sometimes be resource-intensive, requiring extensive design of experiments (DoE) and high-quality process data, making it impractical under fast-paced industrial development timelines. This study proposes a machine learning (ML)-based workflow for developing �fit-for-purpose� digital t
APA, Harvard, Vancouver, ISO, and other styles
3

Pessina, Daniele, Roberto Andrea Abbiati, Davide Manca, and Maria M. Papathanasiou. "Machine learning-enhanced Sensitivity Analysis for Complex Pharmaceutical Systems." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.133428.

Full text
Abstract:
Pharmacokinetic and pharmacodynamic (PK/PD) models are used to predict drug transport in the body and to assess treatment efficacy and optimal dosage. The kinetic parameters embedded in the models, which define transport across body compartments or drug efficacy, can be linked to patient-specific characteristics; understanding the parameter space-model output relationship is critical towards linking patient population heterogeneity to the therapeutic outcome variability. Global Sensitivity Analysis (GSA) is a well-established tool used to examine parameter-to-parameter interactions, shedding l
APA, Harvard, Vancouver, ISO, and other styles
4

Al-Attili, Mais, Carla Ferreira, Chris Price, Karen Faulds, and Yi-Chieh Chen. "In-line spatially offset Raman spectroscopy (SORS) for monitoring pharmaceutical isolation processes." In Applied Industrial Spectroscopy. Optica Publishing Group, 2024. https://doi.org/10.1364/ais.2024.am2a.3.

Full text
Abstract:
This study reports the use of SORS for in-line monitoring of a challenging model system on drying and finds improved performance from the offset configurations with the potential of capturing sample non-uniformity during the drying process.
APA, Harvard, Vancouver, ISO, and other styles
5

Rhim, Jungsoo, and Zoltan Nagy. "Technoeconomic and Sustainability Analysis of Batch and Continuous Crystallization for Pharmaceutical Manufacturing." In Foundations of Computer-Aided Process Design. PSE Press, 2024. http://dx.doi.org/10.69997/sct.107722.

Full text
Abstract:
Continuous manufacturing in pharmaceutical industries has shown great promise to achieve process intensification. To better understand and justify such changes to the current status quo, a technoeconomic analysis of a continuous production must be conducted to serve as a predictive decision-making tool for manufacturers. This paper uses PharmaPy, a custom-made Python-based library developed for pharmaceutical flowsheet analysis, to simulate an annual production cycle for a given active pharmaceutical ingredient (API) of varying production volumes for a batch crystallization system and a contin
APA, Harvard, Vancouver, ISO, and other styles
6

Sibychan, Jerrin Job, Nicola Sorace, Jason Melnick, et al. "Use of Discrete Element Method to Troubleshoot Aesthetic Defects in Pharmaceutical Tablets." In Foundations of Computer-Aided Process Design. PSE Press, 2024. http://dx.doi.org/10.69997/sct.148066.

Full text
Abstract:
Pharmaceutically elegant tablets are an expectation from pharmacists, health care providers and consumers for solid oral dosage forms. The presence of non-aesthetically pleasing defects in solid oral dosage forms can result in complaints back to the manufacturer and potentially non-compliance with medicines. The purpose of this study was to simulate and analyze the design of a tablet core and the aqueous film-coating process, to gain a better understanding of tablet defect generation, and to help eliminate the defects from the finished product. This evaluation employs Discrete Element Method (
APA, Harvard, Vancouver, ISO, and other styles
7

Cao, Xinyu, Yifan Song, Jiayuan Wang, Linyu Zhu, and Xi Chen. "Bayesian Optimization for Enhancing Spherical Crystallization Derived from Emulsions: A Case Study on Ibuprofen." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.158833.

Full text
Abstract:
The pharmaceutical industry is a highly specialized field where strict quality control and accelerated time-to-market are essential for maintaining competitive advantage. Spherical crystallization has emerged as a promising approach in pharmaceutical manufacturing, offering significant potential to reduce equipment and operating costs, enhancing drug bioavailability, and facilitating compliance with product quality regulations. Emulsions, as an enabling technology for spherical crystallization, present unique advantages. However, the quality of spherical crystallization products derived from e
APA, Harvard, Vancouver, ISO, and other styles
8

Zambrano, Consuelo Del Pilar Vega, Nikolaos A. Diangelakis, and Vassilis M. Charitopoulos. "Closed-Loop Data-Driven Model Predictive Control For A Wet Granulation Process Of Continuous Pharmaceutical Tablet Production." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.192802.

Full text
Abstract:
In 2023, the International Council for Harmonisation (ICH) guideline for the development, implementation, and lifecycle management of pharmaceutical continuous manufacturing (PCM), was implemented in Europe. It promotes quality-by-design (QbD) and quality by control (QbC) strategies as well as the appropriate use of mathematical modelling. This development urges a harmonizing understanding across academia and industry for adoption of interpretable models instead of black-box models for advanced control strategies such as model predictive control (MPC), especially when applied in Good Manufactu
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Yunfeng, Yutao Xu, Yong Xiao, Qihui Feng, Yun Zhao, and Yuelang Zhang. "Analysis of the Economic Feasibility of Power Substitution Potential at the Industrial Park Level Based on Mixed-Integer Linear Programming and Its Application in a Pharmaceutical Park." In 2025 International Conference on Electrical Automation and Artificial Intelligence (ICEAAI). IEEE, 2025. https://doi.org/10.1109/iceaai64185.2025.10956523.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lozenko, V. V. "Pharmaceutical names of plants in Latin and English." In PHILOLOGICAL SCIENCES AND TRANSLATION STUDIES: EUROPEAN POTENTIAL. Baltija Publishing, 2021. http://dx.doi.org/10.30525/978-9934-26-110-7-50.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pharmaceutical Potential"

1

Stern, Michael. Group II Metabotropic Glutamate Receptors as Potential Pharmaceutical Targets for Neurofibroma Formation. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada542280.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stern, Michael. Group II Metabotropic Glutamate Receptors as Potential Pharmaceutical Targets for Neurofibroma Formation. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada542347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Silva, Gabriela, Jovânia Oliveira, Maria Eduarda Almeida, Isabela Costa, Suzane Pigossi, and Marcelo Franchin. Unlocking Synergistic Potential: Propolis in combination with pharmaceutical drugs in disease treatment and prevention. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.4.0095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chefetz, Benny, and Jon Chorover. Sorption and Mobility of Pharmaceutical Compounds in Soils Irrigated with Treated Wastewater. United States Department of Agriculture, 2006. http://dx.doi.org/10.32747/2006.7592117.bard.

Full text
Abstract:
Research into the fate of pharmaceutical compounds (PCs) in the environment has focused on aspects of removal efficiency during sewage treatment, degradation in surface water and accumulation in soils and sediments. However, very little information is available on the binding interactions of pharmaceuticals with dissolved organic matter (DOM) originating from wastewater treatment. Such interactions can significantly affect the transport potential of PCs in soils by altering compound affinity for soil particle surfaces. Our primary hypothesis is that the transport potential of PCs in soils is s
APA, Harvard, Vancouver, ISO, and other styles
5

Chefetz, Benny, and Jon Chorover. Sorption and Mobility of Pharmaceutical Compounds in Soils Irrigated with Treated Wastewater. United States Department of Agriculture, 2006. http://dx.doi.org/10.32747/2006.7709883.bard.

Full text
Abstract:
Research into the fate of pharmaceutical compounds (PCs) in the environment has focused on aspects of removal efficiency during sewage treatment, degradation in surface water and accumulation in soils and sediments. However, very little information is available on the binding interactions of pharmaceuticals with dissolved organic matter (DOM) originating from wastewater treatment. Such interactions can significantly affect the transport potential of PCs in soils by altering compound affinity for soil particle surfaces. Our primary hypothesis is that the transport potential of PCs in soils is s
APA, Harvard, Vancouver, ISO, and other styles
6

Schur, Michael. Georgia Exports and Value Chain Study. Asian Development Bank, 2024. http://dx.doi.org/10.22617/tcs240433-2.

Full text
Abstract:
Analyzing how Georgia can diversify its exports, this report shows how it could potentially ramp up its pharmaceutical, apparel, jewelry, and almond exports, and assesses how an effective export strategy would drive more resilient economic growth. Based on stakeholder interviews, it considers the trends, value chains, and opportunities for each of the high potential sectors and explores how Georgia can leverage its location, favorable business environment, and free-trade agreements. Emphasizing the need for greater innovation and strong government support, it recommends taking a “Team Georgia”
APA, Harvard, Vancouver, ISO, and other styles
7

Atal, Juan Pablo, Úrsula Giedion, Catalina Gutiérrez, and Natalia Jorgensen. What is the Opportunity Cost of Financing Branded Drugs?: The case of the Dominican Republic. Inter-American Development Bank, 2023. https://doi.org/10.18235/0012896.

Full text
Abstract:
The availability of numerous beneficial healthcare technologies presents both an opportunity and a challenge: while they have the potential to improve health outcomes, financial constraints limit their widespread adoption. This challenge is further exacerbated by an aging population and shifting epidemiological trends, which place increasing pressure on global healthcare expenditures. To ensure that rising healthcare costs translate into meaningful improvements in population health, it is essential that spending remains sustainable, does not displace other critical investments, and aligns with
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Cheng, and Yue Yang. Impact of adaptive design on reducing the duration of clinical trials in rare cancers: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0081.

Full text
Abstract:
Review question / Objective: Whether the application of adaptive design in clinical trials of rare cancers can shorten the duration of clinical trials? Condition being studied: Currently, the development of innovative drug products (InMPs) for rare cancers faces many challenges, including the difficulty of enrolling sufficient numbers of patients from small and heterogeneous patient populations for clinical trials, and the significant risks of high financial investment, long development times and potential failure from a pharmaceutical company's perspective for rare cancer drugs due to limited
APA, Harvard, Vancouver, ISO, and other styles
9

Collington, Rosie, and William Lazonick. Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access. Institute for New Economic Thinking Working Paper Series, 2022. http://dx.doi.org/10.36687/inetwp176.

Full text
Abstract:
The United States represents the world’s largest market for pharmaceutical drugs. It is also the only advanced economy in the world that does not regulate drug prices. There is no upper threshold for the prices of medicines in the United States. List prices are instead set by manufacturers in negotiation with supply-chain intermediaries, though some federal programs have degrees of discretion in price determinations. In practice, this deregulated system means that drug prices in the United States are generally far higher than in other advanced economies, adversely affecting patient accessibili
APA, Harvard, Vancouver, ISO, and other styles
10

Pikkemaat, M. G., E. D. van Asselt, H. van Egmond, and P. Bikker. Potential occurrence of residues of veterinary pharmaceuticals in animal by-products. Wageningen Food Safety Research, 2023. http://dx.doi.org/10.18174/635927.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!